Revolutionizing outpatient LESS™ technologies to treat back pain .

Purpose

Welcome to NANISX where our purpose is to create, acquire, incubate, and bring to market patented, unique, and essential inventions through our proprietary LESS™ Exposure Advanced Spine Technologies (LEAST™) to propel the movement of spine surgery from hospitals to outpatient centers worldwide.

A Growing Problem

The low back pain market, with 619 million affected in 2020 and expected to rise to 843 million by 2050 due to aging, presents a significant investment opportunity. The increasing prevalence highlights the urgent need for innovative treatments in this expanding sector.

Key Solutions

Focus Areas

We are deeply committed to identifying and nurturing revolutionary innovations that could be the best in class solutions for advancing outpatient spine surgery globally